360 related articles for article (PubMed ID: 27163932)
1. Protection From Glucocorticoid-Induced Osteoporosis by Anti-Catabolic Signaling in the Absence of Sost/Sclerostin.
Sato AY; Cregor M; Delgado-Calle J; Condon KW; Allen MR; Peacock M; Plotkin LI; Bellido T
J Bone Miner Res; 2016 Oct; 31(10):1791-1802. PubMed ID: 27163932
[TBL] [Abstract][Full Text] [Related]
2. SOST gene suppression stimulates osteocyte Wnt/β-catenin signaling to prevent bone resorption and attenuates particle-induced osteolysis.
Jiao Z; Chai H; Wang S; Sun C; Huang Q; Xu W
J Mol Med (Berl); 2023 May; 101(5):607-620. PubMed ID: 37121919
[TBL] [Abstract][Full Text] [Related]
3. Reversing LRP5-dependent osteoporosis and SOST deficiency-induced sclerosing bone disorders by altering WNT signaling activity.
Chang MK; Kramer I; Keller H; Gooi JH; Collett C; Jenkins D; Ettenberg SA; Cong F; Halleux C; Kneissel M
J Bone Miner Res; 2014 Jan; 29(1):29-42. PubMed ID: 23901037
[TBL] [Abstract][Full Text] [Related]
4. Enhanced prostacyclin formation and Wnt signaling in sclerostin deficient osteocytes and bone.
Ryan ZC; Craig TA; Salisbury JL; Carpio LR; McGee-Lawrence M; Westendorf JJ; Kumar R
Biochem Biophys Res Commun; 2014 May; 448(1):83-8. PubMed ID: 24780398
[TBL] [Abstract][Full Text] [Related]
5. Suppression of Sost/Sclerostin and Dickkopf-1 Augment Intervertebral Disc Structure in Mice.
Kroon T; Bhadouria N; Niziolek P; Edwards D; Choi R; Clinkenbeard EL; Robling A; Holguin N
J Bone Miner Res; 2022 Jun; 37(6):1156-1169. PubMed ID: 35278242
[TBL] [Abstract][Full Text] [Related]
6. CYR61/CCN1 Regulates Sclerostin Levels and Bone Maintenance.
Zhao G; Huang BL; Rigueur D; Wang W; Bhoot C; Charles KR; Baek J; Mohan S; Jiang J; Lyons KM
J Bone Miner Res; 2018 Jun; 33(6):1076-1089. PubMed ID: 29351359
[TBL] [Abstract][Full Text] [Related]
7. Sost Haploinsufficiency Provokes Peracute Lethal Cardiac Tamponade without Rescuing the Osteopenia in a Mouse Model of Excess Glucocorticoids.
Javaheri B; Herbert E; Hopkinson M; Al-Jazzar A; Pitsillides AA
Am J Pathol; 2019 Apr; 189(4):753-761. PubMed ID: 30664862
[TBL] [Abstract][Full Text] [Related]
8. Resorption controls bone anabolism driven by parathyroid hormone (PTH) receptor signaling in osteocytes.
Rhee Y; Lee EY; Lezcano V; Ronda AC; Condon KW; Allen MR; Plotkin LI; Bellido T
J Biol Chem; 2013 Oct; 288(41):29809-20. PubMed ID: 23963454
[TBL] [Abstract][Full Text] [Related]
9. Involvement of WNT/β-catenin signaling in the treatment of osteoporosis.
Rossini M; Gatti D; Adami S
Calcif Tissue Int; 2013 Aug; 93(2):121-32. PubMed ID: 23748710
[TBL] [Abstract][Full Text] [Related]
10. Reduction of SOST gene promotes bone formation through the Wnt/β-catenin signalling pathway and compensates particle-induced osteolysis.
Zhang ZH; Jia XY; Fang JY; Chai H; Huang Q; She C; Jia P; Geng C; Xu W
J Cell Mol Med; 2020 Apr; 24(7):4233-4244. PubMed ID: 32134561
[TBL] [Abstract][Full Text] [Related]
11. Heavy Metal Ion Regulation of Gene Expression: MECHANISMS BY WHICH LEAD INHIBITS OSTEOBLASTIC BONE-FORMING ACTIVITY THROUGH MODULATION OF THE Wnt/β-CATENIN SIGNALING PATHWAY.
Beier EE; Sheu TJ; Dang D; Holz JD; Ubayawardena R; Babij P; Puzas JE
J Biol Chem; 2015 Jul; 290(29):18216-18226. PubMed ID: 25975268
[TBL] [Abstract][Full Text] [Related]
12. The role of Wnt signaling and sclerostin in the pathogenesis of glucocorticoid-induced osteoporosis.
Guañabens N; Gifre L; Peris P
Curr Osteoporos Rep; 2014 Mar; 12(1):90-7. PubMed ID: 24488619
[TBL] [Abstract][Full Text] [Related]
13. Estrogen Modulates Bone Morphogenetic Protein-Induced Sclerostin Expression Through the Wnt Signaling Pathway.
Kim RY; Yang HJ; Song YM; Kim IS; Hwang SJ
Tissue Eng Part A; 2015 Jul; 21(13-14):2076-88. PubMed ID: 25837159
[TBL] [Abstract][Full Text] [Related]
14. Sclerostin vaccination mitigates estrogen deficiency induction of bone mass loss and microstructure deterioration.
Wang FS; Wu RW; Lain WS; Tsai TC; Chen YS; Sun YC; Ke HJ; Li JC; Hwang J; Ko JY
Bone; 2018 Jul; 112():24-34. PubMed ID: 29653294
[TBL] [Abstract][Full Text] [Related]
15. Control of Bone Anabolism in Response to Mechanical Loading and PTH by Distinct Mechanisms Downstream of the PTH Receptor.
Delgado-Calle J; Tu X; Pacheco-Costa R; McAndrews K; Edwards R; Pellegrini GG; Kuhlenschmidt K; Olivos N; Robling A; Peacock M; Plotkin LI; Bellido T
J Bone Miner Res; 2017 Mar; 32(3):522-535. PubMed ID: 27704638
[TBL] [Abstract][Full Text] [Related]
16. Wnt Signaling Pathway Inhibitor Sclerostin Inhibits Angiotensin II-Induced Aortic Aneurysm and Atherosclerosis.
Krishna SM; Seto SW; Jose RJ; Li J; Morton SK; Biros E; Wang Y; Nsengiyumva V; Lindeman JH; Loots GG; Rush CM; Craig JM; Golledge J
Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):553-566. PubMed ID: 28062506
[TBL] [Abstract][Full Text] [Related]
17. BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway.
Kamiya N; Ye L; Kobayashi T; Mochida Y; Yamauchi M; Kronenberg HM; Feng JQ; Mishina Y
Development; 2008 Nov; 135(22):3801-11. PubMed ID: 18927151
[TBL] [Abstract][Full Text] [Related]
18. SOST silencing promotes proliferation and invasion and reduces apoptosis of retinoblastoma cells by activating Wnt/β-catenin signaling pathway.
Wu T; Wang LN; Tang DR; Sun FY
Gene Ther; 2017 Jul; 24(7):399-407. PubMed ID: 28485721
[TBL] [Abstract][Full Text] [Related]
19. Role of Wnt signaling and sclerostin in bone and as therapeutic targets in skeletal disorders.
Marini F; Giusti F; Palmini G; Brandi ML
Osteoporos Int; 2023 Feb; 34(2):213-238. PubMed ID: 35982318
[TBL] [Abstract][Full Text] [Related]
20. Fructus Ligustri Lucidi preserves bone quality through induction of canonical Wnt/β-catenin signaling pathway in ovariectomized rats.
Liu H; Guo Y; Zhu R; Wang L; Chen B; Tian Y; Li R; Ma R; Jia Q; Zhang H; Xia B; Li Y; Wang X; Zhu X; Zhang R; Brӧmme D; Gao S; Zhang D; Pei X
Phytother Res; 2021 Jan; 35(1):424-441. PubMed ID: 32755017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]